People with substance use disorders face greater challenges during the COVID-19 pandemic

The closures of businesses and states throughout the U.S. due to the COVID-19 pandemic have been stressful, costly and challenging for many.

But the restrictions do not affect everyone equally. Particularly vulnerable are those with . With schedules disrupted, medical and psychological care curtailed and shut down, the COVID-19 pandemic may jeopardize their recovery.

The COVID-19 pandemic comes on the coattails of the U.S. opioid epidemic. Between 1998 and 2018, about 450,000 people died from opioid overdose.

Progress was being made until COVID-19 appeared. Those of us who work in the field of substance use disorders became concerned for those in recovery as the pandemic spread and social distancing was put in place. Social connection and support are key parts of recovery. Without them, relapse is more likely. When people with opioid use disorder relapse, there’s more involved than a loss of sobriety, ruinous as that is. Often there is a loss of life.

Right now, our team, including the three of us—an associate professor of psychology at IUPUI, an associate professor of sociology at Indiana University Southeast and a psychology professor at Indiana University South Bend – are trying to understand how people with substance use disorders are managing their recovery during the COVID-19 pandemic. Between March and April 2020, we spoke with 45 adults ages 28 to 73, half of whom have opioid use disorder. The other half have a combination of other substance and/or alcohol use disorders. Their stories reflect many challenges, but also some silver linings; they also suggest ways we can do better.

Stress, cravings, hopelessness

The interviewees rated their chances of infection from COVID-19 at 63%. That’s more than double the rating from members of the general community (about 30%). The higher numbers may reflect reality; nearly two-thirds (63%) of our participants report preexisting conditions (such as chronic respiratory illnesses) in themselves or someone in their household. This places them at higher risk for COVID-related complications.

Evidence also suggests that people with substance use disorders are disproportionately more likely to experience homelessness or incarceration, two more for higher COVID-related complications and death.

Adding to the problem: Diagnosing COVID-19 in people who use substances is not always straightforward. Withdrawal may worsen or mimic COVID-19 symptoms. In turn, a COVID-19 infection may aggravate the breathing impacts of opioids, benzodiazepines and alcohol.

We were not surprised that 78% of our sample reported higher stress than before the pandemic, due primarily to increases in job or family responsibilities (42%) and job losses or reductions (30%). These changes in routine, coupled with unstructured free time, make recovery more difficult for them. The added stress contributes to feelings of loneliness, frustration and hopelessness.

Stress can exacerbate substance cravings and contributes to relapse. About 20% of the sample reported increases in cravings, and 17% reported using substances since the pandemic’s start. This may foreshadow an increase in relapse rates as the pandemic continues and in its aftermath.

Less access to support

Study participants report closures of recovery houses, suspensions of in-person support meetings and premature dismissals from treatment centers. Restricting these critical supports creates significant challenges for maintaining sobriety. The majority of respondents indicated they are now attending support meetings online or by phone; a small percentage no longer attend meetings due to cancellations, perceived reductions of support or because meeting forums feel “chaotic” and “not the same.” Those who have lost the communal support of meetings are at substantial risk of relapse.

Overdose reversal medications save lives from opioid overdose. However, some localities are reporting decreased use of overdose reversal medications by first responders to limit COVID-19 transmission.

Many with opioid use disorder rely on lifesaving opioid replacement medications. These treatments often require regular urine monitoring; this is to make sure the medications are not being diverted. But those once-routine visits are now restricted due to COVID-19. Fortunately, the government has developed new guidelines to ease restrictions and enable continued treatment using these replacement medications despite limited monitoring.

On the positive side

Those struggling with drug and alcohol use are showing great resilience in the face of the pandemic; 83% of our sample have maintained sobriety. Many of our respondents say isolation is an opportunity to better connect with friends, family and support group members. Some say they now have more time for journaling, praying, cooking and spending time outside. One individual highlighted the new ability to attend more meetings via online formats. Thus, although these are challenging times, as one participant noted, “[My treatment facility] and Alcoholics Anonymous have prepared me very well for this time.”

What can we do to help those in recovery? Yale University’s Program in Addiction Medicineoffers guidelines for treatment during the pandemic. Flexibility is key. Options include reducing monitoring requirements, which would allow extended take-home doses of opioid replacement medications. Still, individuals should be prepared for limited access to syringe exchange programs, and providers should heighten awareness of blood-borne diseases caused by sharing or reusing needles.

Based on our conversations, interpersonal connections remain at the core of recovery. Online meetings are far from universally helpful. Though it may seem old-school, phone calls, physical letters or other personalized contacts may have significant roles to play in maintaining support networks.

Individuals and groups looking for ways to contribute might contact local agencies to coordinate donations of letters, masks or other tokens of encouragement for distribution among clients. To ensure their sustained sobriety, we must support people in recovery who need access to health care, stable housing and community. And then it is our responsibility to remain mindful of those needs after the pandemic becomes a memory.

Follow the latest news on the coronavirus (COVID-19) outbreak

Provided by
The Conversation

This article is republished from The Conversation under a Creative Commons license. Read the original article.The Conversation

People with substance use disorders face greater challenges during the COVID-19 pandemic (2020, May 19)
retrieved 19 May 2020

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Related posts:

WHO-Studie: Jeder fünfte Jugendliche in Deutschland ist zu dick
What does recovery from COVID-19 look like?
Researchers develop high-performance cancer vaccine using novel microcapsules
COVID-19 trial finder provides simplified search process for COVID-related clinical trials
Epilepsy-related deaths common in young adults and are not reducing, new research shows
Brazil surges to second in coronavirus cases worldwide
DKFZ: Drei Maßnahmen könnten eine Million Krebsfälle vermeiden
COVID-19: Ulmer Forscher untersuchen in neuer Therapiestudie Wirkung von Ruxolitinib
Common misunderstandings doctors confront about preventing pregnancy
Scientists raise concern over hydroxychloroquine study
Cell therapy treatment for cardiac patients with microvascular dysfunction provides enhanced quality
COVID-19 death counts 'substantial underestimation' of actual deaths for some Italian regions
Study sheds light on risks of breast cancer after pre-invasive disease
Researchers identify mechanisms that make skin a protective barrier
Heart surgery stalled as COVID-19 spread
„Schlankmacher“-Gen heizt Fettverbrennung an - Biermann Medizin
Study finds association between atherosclerosis and changes in the structure, heart function
Biochemie-Absolvent der Universität Bayreuth hat Antigen für SARS-CoV-2-Antikörpertest entwickelt
Researchers use brain imaging to demonstrate weaker neural suppression for those with autism
Local climate unlikely to drive the early COVID-19 pandemic
Chemists develop foolproof new test to track the fats we eat
MEDucation TV: Medizinische Fortbildung digital
Madagascar's 'green gold' against COVID-19 seeks nod beyond Africa
Schmerzen bei Rheuma: Immer mehr Patienten nehmen Opioide ein
Leberkrebs: Forderung nach mehr Aufmerksamkeit in Bezug auf Hepatitis D
Treating skin irritations from wearing face masks
Mayo Clinic Minute: Health benefits of gardening
Virologe Streeck wehrt sich gegen Vorwürfe: „Doof gelaufen“
Large-scale vaccine testing expected by July
UK govt boosts vaccine funding as daily virus deaths fall
UK to introduce 14-day quarantine for international arrivals
Coronavirus befällt auch Nieren und andere Organe
Forscher bestätigen Zusammenhang zwischen CED und Zöliakie
US health officials quietly release more reopening guidance
Americans and Europeans soak up the sun amid new rules
Multiple sclerosis risk 29% higher for people living in urban areas, new research reveals
Deutsche Zigarettenautomaten könnten Fall für den EuGH werden
Deutsche Krebshilfe und die Arbeitsgemeinschaft Dermatologische Prävention raten zu neuer Normalität...
High-quality end-of-life care will enable older people with frailty to live well and die well
Liverpool-Atletico match linked to '41 additional' virus deaths: report
Blood clotting abnormalities reveal COVID-19 patients at risk for thrombotic events
Sondererhebung in der Corona-Krise: Medizinklimaindex fällt auf -25,1
SPD-Experte widerspricht Kinderärzten bei Öffnung von Schule und Kita
Overcoming challenges of individuals with autism during the COVID-19 pandemic
As Ohio abortion regulations increased, disparities in care emerged
Krankenhauskeime mit UVC-Leuchtdioden bekämpfen
High-tech devices help NFL teams keep players safe, in shape
Public information key to combating rising 'superbug' threat
Nearly half of Moroccans 'anxious' under lockdown: study
Loosened restrictions, holiday weekend to test California
Researchers urge clinical trial of blood pressure drug to prevent complication of COVID-19
Abnormalities detected on brain MRI of COVID-19 patients in ICU
Dairy-rich diet linked to lower risks of diabetes and high blood pressure
Tumorschmerz beim Pankreaskarzinom: Komplexe Interaktion zwischen Tumorzellen und Nerven
New study could pave way to cure of global parasite
Funktion des Nierenfilters geklärt - Biermann Medizin
Incidence of AMI hospitalization down during COVID-19
Neuartiges COVID-19-Schnelltestverfahren auf Basis innovativer DNA-Polymerasen entwickelt
Studie enthüllt viele Möglichkeiten, wie Karzinogene die Entwicklung von Brustkrebs auslösen
Ist das Nervensystem bei SARS-CoV-2-Infektionen beteiligt?
Mit Hochdurchsatz gegen Krebs und COVID-19
Insomnia may forecast depression, thinking problems in older people
Germany kicks off as Europe eases curbs but virus marches on
Antikörper erkennt Alzheimer-Pathogene - Biermann Medizin
Half of moms-to-be at risk of preeclampsia are missing out on preventive aspirin
Misleading information in 1 in 4 most viewed YouTube COVID-19 videos in English
US regulators approve new type of contraceptive gel
Warum Lymphdrüsenkrebs das Gehirn befällt
UK PM Johnson backs key aide over lockdown breach claims
AI successfully used to identify different types of brain injuries
Public health campaigns can do better on cannabis harm reduction
Study reveals mental health of medical personnel working with COVID-19 patients
Klaus Tschira Stiftung unterstützt Sepsis-Forschung
DJO stärkt DACH-Region - Biermann Medizin
Endgültiges Aus für Mentholzigarette in der EU
Chirurgie-Ausbildung mit Roboter und Virtueller Realität
AbbVie schließt Übernahme von Allergan ab
'COVID toes,' other rashes latest possible rare virus signs
its impact cannot be explained away through the prism of race
Möglicher Übertragungsweg? Erstmals SARS-CoV-2 in Muttermilch nachgewiesen
Study traces brain-to-gut connections
Surgery and radiation do not extend survival in newly diagnosed metastatic breast cancer
Biomarkers may help us understand recovery time after concussion
Krankheitserreger nutzen Stickstoffmonoxid bei der Schleimhaut-Besiedlung
Majority of cannabis use in Vancouver's Downtown Eastside for therapeutic purposes
Gehirnmetastasen: Erleichtert Fluoreszenz-Markierung die operative Entfernung von Tumoren?
Russia's virus spread stabilising: top health official
Tackling airborne transmission of COVID-19 indoors
Kritik am Patientendaten-Schutzgesetz - Biermann Medizin
Kontaktekzem: Biologischer Wirkstoff mögliche Therapieoption
Neue Erkenntnisse zur Wirkweise von Ketamin
Assessing cancer diagnosis in children with birth defects
Immunantwort nach Corona-Infektion im Blick
DGU: Mit risikoadaptiertem PSA-Screening nicht bis 2028 warten
These coronavirus 'carriers' take test samples around London
Infopaket geschnürt: Von der Lupe bis zum Laser-Blindenstock
Demenz-Gen erhöht das Risiko für schweres COVID-19
Roboter hilft Pflegenden - Biermann Medizin
E-Zigaretten: Experten sind uneins über den Nutzen der E-Zigarette bei der Entwöhnung
5 ways to help stop the 'infodemic,' the increasing misinformation about coronavirus

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

HCC: Neue Kombinationstherapie könnte Überleben von Patienten verlängern

Tue May 19 , 2020
Zum ersten Mal seit über einem Jahrzehnt haben Wissenschaftler eine Erstlinientherapie identifiziert, die das Überleben von Menschen mit Hepatozellulärem Karzinom (HCC) signifikant verbessert. Die Forscher fanden heraus, dass die Kombination von Atezolizumab (einem humanisierten monoklonalen Antikörper der Klasse IgG1κ gegen PD-L1) und Bevacizumab (einem Angiogenese-Hemmer) , das das Wachstum der […]